Category : Search result: NHS obesity treatment


Mounjaro Beats Wegovy in Weight Loss Study

Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.

NHS to prescribe Mounjaro for weight loss in major shift

The NHS is poised to prescribe diabetes medication Mounjaro for weight loss in a groundbreaking move that could help millions of Britons struggling with obesity. Health Secretary Wes Streeting announces major expansion of weight management services.

Weight Loss Jabs: NHS Faces £20 Billion Crisis

Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.

NHS denies 'miracle' weight-loss drug to desperate mother

Exclusive: Carly Stokes, a mother battling severe obesity, is denied access to the 'game-changer' drug Tirzepatide (Mounjaro) on the NHS despite its proven success, sparking outrage and a debate on healthcare funding.

New Weight Loss Jab Helps Shed Over 20% Body Weight

A landmark UK study reveals the new weight loss injection Tirzepatide is significantly more effective than existing treatments, helping patients lose over 20% of their body weight and offering new hope in the fight against obesity.

New Weight Loss Pill Cuts Body Weight By 20%

Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.

Weight-loss jabs transform child obesity treatment

Groundbreaking NHS research reveals obesity injections like Wegovy are dramatically more effective than lifestyle changes alone for teenagers, offering new hope in the childhood obesity crisis.

NHS Breast Cancer Care Postcode Lottery Exposed

Exclusive investigation reveals stark regional disparities in NHS breast cancer care across England, with patients facing unacceptable treatment delays and fragmented services despite government promises.

NHS's Triple-Strength Mega-Dose Wegovy for Obesity

The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.

TikTok's Dangerous 'Skinny Jab' Trend Exposed

Exclusive investigation reveals the alarming trend of unregulated weight-loss jabs like Retatrutide being promoted on TikTok, posing severe health risks to UK users desperate for quick fixes.

Sussex NHS Trust Placed Under 'Enhanced Support' Amid Crisis

The NHS Sussex integrated care board has been escalated to 'tier 2' oversight following a review that uncovered significant failings in its leadership and culture, raising serious concerns for health services across Brighton and East Sussex.

NHS Strike Escalation Threat Over Outsourcing Plans

Exclusive: The UK government faces imminent NHS strike escalation as unions vow to combat plans replacing striking staff with outsourced workers, potentially prolonging the largest walkout in health service history.

NHS to Offer 'Game-Changer' Mounjaro Weight Loss Jab

The NHS in England is set to provide the highly effective Mounjaro (tirzepatide) weight-loss injection, hailed as a major breakthrough in fighting obesity and related diseases like type 2 diabetes.

NHS Expands 'Game-Changer' Weight Loss Jab Rollout

The NHS is dramatically expanding the availability of prescription weight-loss injections, hailed as a 'game-changer' in treating obesity. This major rollout could benefit hundreds of thousands more patients across England.

Weight Loss Microdosing: A UK Medical Breakthrough?

UK researchers are exploring a revolutionary 'microdosing' strategy for powerful weight-loss medications like Wegovy, potentially slashing costs and side effects while boosting accessibility for NHS patients.

NHS Weight Loss Jab Postcode Lottery Exposed

Exclusive investigation reveals the staggering postcode lottery and soaring costs of life-changing obesity drugs like Mounjaro and Wegovy, as the NHS struggles to cope with unprecedented demand.

New Drug Beats Ozempic in Weight Loss and Heart Health

Groundbreaking UK study reveals a new diabetes medication, Mounjaro (tirzepatide), achieves significantly greater weight loss and superior cardiovascular benefits compared to Ozempic, revolutionising obesity treatment.

Page 3 of 4